SIGA(SIGA Technologies, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $133.67M | $110.78M | $139.92M | $138.72M | $94.57M |
| 毛利润 | $117.07M | $100.34M | $122.09M | $107.43M | $64.87M |
| 营业利润 | $89.09M | $42.70M | $83.62M | $69.98M | $23.70M |
| 净利润 | $69.45M | $33.90M | $68.07M | $59.21M | $23.28M |
| 经营现金流 | $11.49M | $41.61M | $94.80M | $48.76M | $43.47M |
| 自由现金流 | $11.44M | $41.61M | $94.78M | $48.72M | $43.12M |
| 摊薄每股收益 | $0.91 | $0.46 | $0.95 | $0.82 | $0.32 |